The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells

Christine Galustian(St George's, University of London), B Meyer(St George's, University of London), Marie‐Christine Labarthe(St George's, University of London), Keith Dredge(St George's, University of London), Deborah Klaschka(St George's, University of London), Jake Y. Henry(St George's, University of London), Stephen Todryk(Churchill Hospital), Roger Chen(Bristol-Myers Squibb (Switzerland)), George W. Muller(Bristol-Myers Squibb (Switzerland)), David Stirling(Bristol-Myers Squibb (Switzerland)), Peter Schäfer(Bristol-Myers Squibb (Switzerland)), J. Blake Bartlett(Bristol-Myers Squibb (Switzerland)), Angus Dalgleish(St George's, University of London)
Cancer Immunology Immunotherapy
November 13, 2008
Cited by 386Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis